As Regeneron Pharmaceuticals (REGN) Stock Value Rose, Halsey Associates Has Boosted Holding; Fastenal Co (FAST) Shareholder Trexquant Investment LP Trimmed Its Stake

February 21, 2018 - By Adrian Erickson

Halsey Associates Inc increased its stake in Regeneron Pharmaceuticals (REGN) by 74.89% based on its latest 2017Q3 regulatory filing with the SEC. Halsey Associates Inc bought 6,458 shares as the company’s stock rose 21.24% with the market. The institutional investor held 15,081 shares of the health care company at the end of 2017Q3, valued at $6.74 million, up from 8,623 at the end of the previous reported quarter. Halsey Associates Inc who had been investing in Regeneron Pharmaceuticals for a number of months, seems to be bullish on the $34.25 billion market cap company. The stock decreased 1.45% or $4.69 during the last trading session, reaching $318.35. About 357,416 shares traded. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has risen 17.40% since February 21, 2017 and is uptrending. It has outperformed by 0.70% the S&P500.

Trexquant Investment Lp decreased its stake in Fastenal Co (FAST) by 35.78% based on its latest 2017Q3 regulatory filing with the SEC. Trexquant Investment Lp sold 12,918 shares as the company’s stock declined 14.06% while stock markets rallied. The institutional investor held 23,182 shares of the building materials company at the end of 2017Q3, valued at $1.06M, down from 36,100 at the end of the previous reported quarter. Trexquant Investment Lp who had been investing in Fastenal Co for a number of months, seems to be less bullish one the $15.75 billion market cap company. The stock increased 0.94% or $0.51 during the last trading session, reaching $54.75. About 442,089 shares traded. Fastenal Company (NASDAQ:FAST) has declined 2.09% since February 21, 2017 and is downtrending. It has underperformed by 18.79% the S&P500.

Trexquant Investment Lp, which manages about $105.00M and $396.96M US Long portfolio, upped its stake in Amdocs Ltd (NASDAQ:DOX) by 8,011 shares to 11,711 shares, valued at $753,000 in 2017Q3, according to the filing. It also increased its holding in Immunomedics Inc (NASDAQ:IMMU) by 50,939 shares in the quarter, for a total of 79,923 shares, and has risen its stake in Caterpillar Inc Del (NYSE:CAT).

Investors sentiment increased to 1.3 in Q3 2017. Its up 0.01, from 1.29 in 2017Q2. It increased, as 50 investors sold FAST shares while 161 reduced holdings. 62 funds opened positions while 213 raised stakes. 234.48 million shares or 1.45% more from 231.14 million shares in 2017Q2 were reported. Stephens Inv Management Grp Inc Limited Liability Com accumulated 68,686 shares or 0.07% of the stock. Engineers Gate Manager Lp, New York-based fund reported 52,931 shares. Point72 Asset Mgmt Lp holds 0.01% or 59,400 shares in its portfolio. Wilkins Inv Counsel Inc owns 107,675 shares. Greenleaf accumulated 0.02% or 17,465 shares. Principal Gp Incorporated stated it has 2.47M shares or 0.11% of all its holdings. Moreover, Rand Wealth Ltd Liability has 0.04% invested in Fastenal Company (NASDAQ:FAST) for 8,240 shares. Hartline Invest Corporation holds 0.3% or 21,762 shares in its portfolio. Brinker Capital accumulated 84,496 shares. Deutsche Bancorporation Ag, a Germany-based fund reported 1.62M shares. Roberts Glore And Communication Il holds 0.14% of its portfolio in Fastenal Company (NASDAQ:FAST) for 4,841 shares. State Street has 0.05% invested in Fastenal Company (NASDAQ:FAST). 5,772 are held by Veritable Lp. State Of Tennessee Treasury Department has 78,710 shares. State Bank Of Nova Scotia accumulated 0.02% or 71,903 shares.

Among 17 analysts covering Fastenal (NASDAQ:FAST), 9 have Buy rating, 0 Sell and 8 Hold. Therefore 53% are positive. Fastenal had 63 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Fastenal Company (NASDAQ:FAST) earned “Hold” rating by BMO Capital Markets on Monday, January 8. The firm has “Outperform” rating by Credit Suisse given on Wednesday, April 19. The rating was initiated by KeyBanc Capital Markets with “Sector Weight” on Tuesday, July 21. The firm has “Buy” rating by Stephens given on Friday, June 2. The stock of Fastenal Company (NASDAQ:FAST) earned “Market Perform” rating by BMO Capital Markets on Tuesday, April 5. The firm has “Neutral” rating by Credit Suisse given on Tuesday, September 15. Barclays Capital maintained the stock with “Underweight” rating in Monday, October 5 report. Robert W. Baird maintained Fastenal Company (NASDAQ:FAST) rating on Thursday, October 12. Robert W. Baird has “Buy” rating and $53.0 target. The stock has “Buy” rating by Argus Research on Tuesday, March 8. Stephens maintained it with “Buy” rating and $62.0 target in Wednesday, January 17 report.

Analysts await Fastenal Company (NASDAQ:FAST) to report earnings on April, 11. They expect $0.60 EPS, up 30.43% or $0.14 from last year’s $0.46 per share. FAST’s profit will be $172.56M for 22.81 P/E if the $0.60 EPS becomes a reality. After $0.45 actual EPS reported by Fastenal Company for the previous quarter, Wall Street now forecasts 33.33% EPS growth.

Since October 16, 2017, it had 0 insider purchases, and 3 selling transactions for $2.10 million activity. 26,250 Fastenal Company (NASDAQ:FAST) shares with value of $1.48 million were sold by Miller Charles S.. 10,000 shares valued at $471,350 were sold by Hein LeLand J on Monday, October 16.

Investors sentiment decreased to 1.17 in 2017 Q3. Its down 0.21, from 1.38 in 2017Q2. It worsened, as 56 investors sold REGN shares while 165 reduced holdings. 71 funds opened positions while 187 raised stakes. 73.70 million shares or 3.04% more from 71.53 million shares in 2017Q2 were reported. Gateway Invest Advisers Limited Liability Company invested 0.02% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Guggenheim Capital Ltd Liability Company stated it has 0.17% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Invesco reported 897,376 shares or 0.15% of all its holdings. Duquesne Family Office Ltd Liability Co holds 0.65% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) or 31,800 shares. State Of New Jersey Common Pension Fund D accumulated 0.01% or 3,000 shares. Texas-based Exxonmobil Investment Mngmt Incorporated Tx has invested 0.16% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Baystate Wealth Ltd invested in 0% or 7 shares. 27 were reported by Thompson Davis And Co. Sumitomo Life Ins reported 5,402 shares. Legal And General Grp Public Ltd Company holds 371,110 shares. Assetmark Inc has 0% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 61 shares. Nippon Life accumulated 6,522 shares. Moreover, Girard Ptnrs has 0.04% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 467 shares. Cwm Ltd Company accumulated 0% or 33 shares. Vantage Inv Advsr holds 167 shares.

Halsey Associates Inc, which manages about $849.92 million and $507.35M US Long portfolio, decreased its stake in Apple (NASDAQ:AAPL) by 5,878 shares to 156,260 shares, valued at $24.08M in 2017Q3, according to the filing. It also reduced its holding in Paypal by 20,400 shares in the quarter, leaving it with 234,136 shares, and cut its stake in Berkshire Hathaway B (BRKB).

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>